Physician profile
Nikhil Verma
NPI 1659350353
$646,867.71
in general payments reported to CMS, 2019-2025
24 companies · $188K in 2025
The $188K reported for 2025 was more than what 98% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $33K · 2021: $104K · 2022: $101K · 2023: $75K · 2024: $114K · 2025: $188K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $276K · Consulting Fee: $92K · Food and Beverage: $4,467 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,680 · Travel and Lodging: $1,856 · Education: $93.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $275,789.22 |
| Consulting Fee | $91,850.00 |
| Food and Beverage | $4,466.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,680.00 |
| Travel and Lodging | $1,855.88 |
| Education | $93.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $270,913.00 | 2020-2025 | Arthrex, Ar-19021tt |
| Stryker Corporation | $200,255.19 | 2019-2025 | Alphavent, Aequalis, Iconix |
| Smith+Nephew, INC. | $167,235.98 | 2019-2025 | Biceptor, Mini-Open Latarjet, Acufex Director |
| Graymont Professional Products Ip, LLC | $5,000.00 | 2019 | |
| Relievant Medsystems, INC. | $693.77 | 2019 | |
| Abbott Laboratories | $640.53 | 2021-2023 | Proclaim |
| Spinal Simplicity, LLC | $573.87 | 2022 | |
| Breg, INC | $340.50 | 2020-2025 | |
| Nalu Medical, INC. | $222.35 | 2021 | |
| Ossur Americas, INC. | $124.45 | 2024 | Miami J |
| Foundation Fusion Solutions, LLC | $120.70 | 2022 | |
| Nevro Corp. | $116.45 | 2020 | |
| Pinnacle, INC | $99.99 | 2024 | |
| Medwest Associates | $95.24 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $91.68 | 2020-2025 | Exparel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $43.27 | 2021 | |
| Orthofix Medical, INC. | $42.58 | 2019-2023 | Physio-Stim |
| Vericel Corporation | $37.78 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.42 | 2021 | |
| Vertos Medical, INC. | $23.92 | 2021 | |
| Depuy Synthes Sales INC. | $23.64 | 2019 | |
| Ibsa Pharma INC. | $18.15 | 2021 | |
| Pacira Therapeutics, INC. | $16.38 | 2021 | |
| Corium, LLC | $14.16 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.